Skip to main content

JPMORGAN CHASE & CO

Position in CLDX — Celldex Therapeutics, Inc.

CIK 19617 NEW YORK, NY

Position in CLDX

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$5,850,936
+$624,180 QoQ
Shares Held
157,241
-4.6% QoQ
Ownership
0.200%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#67
of 252 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 61% Shared 0% None 39%

Common Shares in CLDX Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

JPMORGAN CHASE & CO holds $12,920,143,243 across 425 Biotechnology names. CLDX ranks #104 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in CLDX

Export CSV
26 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $5,850,936 157,241
2026-03-31 $5,226,756 164,778
2025-12-31 $4,717,066 173,677
2025-09-30 $4,780,128 184,775
2025-06-30 $4,758,256 233,821
2025-03-31 $4,380,573 241,354
2024-12-31 $2,161,720 85,545
2024-09-30 $1,729,239 50,875
2024-06-30 $2,086,030 56,364
2024-03-31 $1,962,306 46,755
2023-12-31 $2,993,139 75,470
2023-09-30 $1,724,869 62,677
2023-06-30 $3,386,993 99,823
2023-03-31 $2,576,634 71,613
2022-12-31 $2,141,810 48,055
2022-09-30 $1,205,889 42,899
2022-06-30 $1,141,647 42,346
2022-03-31 $1,188,284 34,888
2021-12-31 $4,939,504 127,834
2021-09-30 $11,416,344 211,453
2021-06-30 $507,919 15,189
2021-03-31 $2,223 108
2020-12-31 $2,925 167
2020-09-30 $978 66
2020-06-30 $858 66
2020-03-31 $109 66